 8. Topical therapy within 2 weeks of randomization including, but not limited to, topical corticosteroids, retinoids or vitamin D analog preparations, tacrolimus, pimecrolimus, or anthralindithranol. Use of phototherapy within 4 weeks prior to randomization. 